In summary our study demonstrates that H2A.Zac nucleosome incorporation plays a key role in facilitation of ectopic activation of AR-enhancers, which has major implications regarding the mechanism of oncogene deregulation and potential chromatin therapy options for prostate cancer. Here, AR is linked to Familial prostate cancer.